Atlas Trials

A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

Clinical trial NCT06863831 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06863831
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2024-08-22
Primary completion
2025-10-31
Enrollment
536

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.